Linezolid and Plerixafor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Linezolid (linezolid) and Plerixafor (plerixafor). Common drug interactions include acute myeloid leukaemia among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Linezolid and Plerixafor. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Linezolid?

Linezolid has active ingredients of linezolid. It is often used in infection. eHealthMe is studying from 21,891 Linezolid users. Check the latest studies of Linezolid.

What is Plerixafor?

Plerixafor has active ingredients of plerixafor. eHealthMe is studying from 694 Plerixafor users. Check the latest studies of Plerixafor.

On Jul, 05, 2026

13 people who take Linezolid and Plerixafor together, and have interactions are studied.

Linezolid and Plerixafor drug interactions.

What are the common drug interactions of Linezolid and Plerixafor, by gender? *:

female:

Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Acute respiratory failure
Hepatic failure (liver failure)
Hypotension (abnormally low blood pressure)
Pneumonia
Septic shock (shock due to blood infection)
Acute febrile neutrophilic dermatosis (skin disease characterized by the sudden onset of fever, leukocytosis, and tender)
Haemoglobin decreased
Platelet count decreased
White blood cell count decreased

male:

Diarrhoea
Pyrexia (fever)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Hypokalaemia (low potassium)
Rash
Septic shock (shock due to blood infection)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
Body temperature increased
Escherichia infection (bacterial infection by escherichia coli)

What are the common drug interactions of Linezolid and Plerixafor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Body temperature increased
Diarrhoea
Escherichia infection (bacterial infection by escherichia coli)
Febrile neutropenia (fever with reduced white blood cells)
Frequent bowel movements
Hypotension (abnormally low blood pressure)
Leukopenia (less number of white blood cells in blood)
Pyrexia (fever)
Acute febrile neutrophilic dermatosis (skin disease characterized by the sudden onset of fever, leukocytosis, and tender)

50-59:

Constipation
Cough
Diarrhoea
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Hypokalaemia (low potassium)
Pyrexia (fever)
Rash
Septic shock (shock due to blood infection)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)

60+:

Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Acute respiratory failure
Bone marrow failure
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Facial paralysis (loss of function of face muscle)
Hemiplegia (paralysis of one side of the body)
Metapneumovirus infection (infection with human metapneumovirus)
Parainfluenzae virus infection
Plasma cell myeloma (cancer that begins in plasma cells)
Pneumatosis intestinalis (air or gas in an intestine)

What are the existing conditions these people have? *

Adverse Event: 5 people, 38.46%
Multiple Myeloma (cancer of the plasma cells): 4 people, 30.77%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 30.77%
Pulmonary Mass: 2 people, 15.38%
Nocardia Infection (a bacterial infection that usually starts in the lungs. it may spread to other organ systems): 2 people, 15.38%
Metapneumovirus Infection (infection with human metapneumovirus): 2 people, 15.38%
Urination - Excessive Volume: 1 person, 7.69%
Type 2 Diabetes: 1 person, 7.69%
Neuropathy Peripheral (surface nerve damage): 1 person, 7.69%
Hypokalemia (low potassium): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Linezolid and Plerixafor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously